Patent: 9,700,486
✉ Email this page to a colleague
Summary for Patent: 9,700,486
Title: | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
Abstract: | The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, GAMMAGARD LIQUID (an immune globulin infusion (human)); ADVATE (Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method, (rAHF)); BAX 111 (vonicog alfa, or [618-threonine,709-aspartic acid] von Willebrand factor Homo sapiens (1381A>T,1472H>D variant)); or an adeno-associated viral vector containing a liver-specific human factor IX expression cassette, e.g., sscAAV2/8-LP1-hFIXco. |
Inventor(s): | Weeks; Wendell P. (Corning, NY), Schaut; Robert Anthony (Painted Post, NY), DeMartino; Steven Edward (Painted Post, NY), Peanasky; John Stephen (Big Flats, NY) |
Assignee: | Corning Incorporated (Corning, NY) |
Application Number: | 14/259,273 |
Patent Claims: | see list of patent claims |
Details for Patent 9,700,486
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | HELIXATE FS, KOGENATE, KOGENATE FS | antihemophilic factor (recombinant) | For Injection | 103332 | 08/20/2002 | ⤷ Try a Trial | 2033-04-24 |
Bayer Healthcare Llc | HELIXATE FS, KOGENATE, KOGENATE FS | antihemophilic factor (recombinant) | For Injection | 103332 | 06/07/2007 | ⤷ Try a Trial | 2033-04-24 |
Bayer Healthcare Llc | HELIXATE FS, KOGENATE, KOGENATE FS | antihemophilic factor (recombinant) | For Injection | 103332 | 07/31/2009 | ⤷ Try a Trial | 2033-04-24 |
Baxalta Us Inc. | BIOCLATE (ARMOUR), RECOMBINATE | antihemophilic factor (recombinant) | For Injection | 103375 | 12/10/1992 | ⤷ Try a Trial | 2033-04-24 |
Baxalta Us Inc. | BIOCLATE (ARMOUR), RECOMBINATE | antihemophilic factor (recombinant) | For Injection | 103375 | 03/10/2010 | ⤷ Try a Trial | 2033-04-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |